Identification of genes down-regulated during lung cancer progression: a cDNA array study.
BACKGROUND
Lung cancer remains a major health challenge in the world. Survival for patients with stage I disease ranges between 40-70%. This suggests that a significant proportion of patients with stage I NSCLC may actually be under-staged.


METHODS
In order to identify genes relevant for lung cancer development, we carried out cDNA array experiments employing 64 consecutive patients (58 men and 6 women) with a median age of 58 years and stage 1 or stage 2 non-small-cell lung cancer (NSCLC).


RESULTS
Basic cDNA array data identified 14 genes as differentially regulated in the two groups. Quantitative RT-PCR analysis confirmed an effective different transcriptional regulation of 8 out of 14 genes analyzed. The products of these genes belong to different functional protein types, such as extra-cellular matrix proteins and proteases (Decorin and MMP11), genes involved in DNA repair (XRCC1), regulator of angiogenesis (VEGF), cell cycle regulators (Cyclin D1) and tumor-suppressor genes (Semaphorin 3B, WNT-5A and retinoblastoma-related Rb2/p130). Some previously described differences in expression patterns were confirmed by our array data. In addition, we identified and validated for the first time the reduced expression level of some genes during lung cancer progression.


CONCLUSIONS
Comparative hybridization by means of cDNA arrays assisted in identifying a series of novel progression-associated changes in gene expression, confirming, at the same time, a number of previously described results.
Campioni
Mara
M
Department of Biochemistry and Biophysics F, Cedrangolo, Section of Pathology, Second University of Naples, Naples, Italy. maracampioni@yahoo.it
Ambrogi
Vincenzo
V
Pompeo
Eugenio
E
Citro
Gennaro
G
Castelli
Mauro
M
Spugnini
Enrico P
EP
Gatti
Antonio
A
Cardelli
Pierluigi
P
Lorenzon
Laura
L
Baldi
Alfonso
A
Mineo
Tommaso C
TC
D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000473:pathology; D015536:Down-Regulation; D005260:Female; D020869:Gene Expression Profiling; D016147:Genes, Tumor Suppressor; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis
Exp Dermatol. 2003 Apr;12(2):213-8
12702151
J Clin Pathol. 2004 Jun;57(6):591-7
15166262
Oncol Rep. 2008 Jun;19(6):1533-9
18497961
Anticancer Res. 2003 Nov-Dec;23(6C):4901-5
14981943
Mol Cancer. 2005 May 09;4(1):18
15882455
Ann Thorac Surg. 2000 Mar;69(3):882-6
10750777
Clin Cancer Res. 2002 Apr;8(4):1127-38
11948124
Am J Respir Cell Mol Biol. 1998 Feb;18(2):213-7
9476908
Am J Respir Crit Care Med. 1997 Dec;156(6):1930-6
9412577
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11432-7
15273288
Lancet. 1992 Jul 18;340(8812):145-6
1378165
J Cell Biochem. 1996 Sep 1;62(3):418-30
8872613
J Exp Clin Cancer Res. 2007 Dec;26(4):443-9
18365537
Anticancer Res. 2006 Sep-Oct;26(5A):3455-9
17094466
J Clin Pathol. 2005 Jul;58(7):734-9
15976342
Cancer. 2001 Apr 15;91(8):1500-9
11301398
J Mol Med (Berl). 2008 Mar;86(3):259-66
17952396
Clin Cancer Res. 1997 Oct;3(10):1691-7
9815552
Eur J Cancer. 2000 Mar;36(5):601-9
10738124
Ann Thorac Surg. 2001 Mar;71(3):949-54; discussion 954-5
11269479
Cancer Res. 1997 Aug 15;57(16):3381-5
9270000
Cancer Res. 2006 Nov 1;66(21):10439-48
17079465
Environ Health Perspect. 1995 Nov;103 Suppl 8:131-42
8741773
Ann Thorac Surg. 1999 Apr;67(4):927-32
10320230
Clin Cancer Res. 2000 Mar;6(3):1086-92
10741738
Histol Histopathol. 2006 Apr;21(4):423-35
16437388
Lung Cancer. 2006 Dec;54(3):285-92
17034901
Cancer Res. 2002 Jan 15;62(2):409-16
11809689
Neoplasia. 2005 May;7(5):457-65
15967098
Cancer Res. 2007 Sep 15;67(18):8708-15
17875711
Ann Thorac Surg. 2001 Oct;72(4):1144-8
11603427
Histopathology. 2004 Jan;44(1):54-63
14717670
J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43
10096969
Hum Pathol. 1997 Feb;28(2):233-7
9023408
Annu Rev Physiol. 2002;64:681-708
11826285
Cancer. 1995 Sep 1;76(5):787-96
8625181
BMC Cancer. 2007 Aug 16;7:162
17705814
Anticancer Res. 2000 Sep-Oct;20(5A):3301-5
11062757
J Clin Oncol. 1984 Dec;2(12):1352-8
6512581